• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西太平洋地区糖尿病流行病学:聚焦菲律宾。

Epidemiology of diabetes mellitus in Western pacific region: focus on Philippines.

作者信息

Lantion-Ang L C

机构信息

Unit 25, Facilities Centre, The Philippine Diabetes Association INC, 548 Shaw Boulevard, Mandaluyong, Philippines.

出版信息

Diabetes Res Clin Pract. 2000 Oct;50 Suppl 2:S29-34. doi: 10.1016/s0168-8227(00)00176-5.

DOI:10.1016/s0168-8227(00)00176-5
PMID:11024581
Abstract

The aim of Diabcare-Asia project was to collect data on diabetes control, management and complication status among patients in 12 Asian countries. Information was extracted from medical records, interviews and laboratory assessment. The majority (96%) of patients were diagnosed with type 2 diabetes mellitus, with mean age (+/-SD) of 59.3+/-12.5 years and mean diabetes duration of 9.4+/-7.0 years. Mean body mass index (BMI) was 24.7+/-4.9 kg/m(2) and the majority (60%) had BMI < or =25 kg/m(2). The majority (70%) of patients were treated with oral antidiabetic drugs (OADs), 15% with insulin, 10% with insulin and OAD combination therapy and 5% with diet control. Among OADs-treated patients, most (44%) received two or more medication. Majority of patients (> or =79%) had satisfactory metabolic control of triglycerides (<2.2 mmol/l), total cholesterol (<6.5 mmol/l) and HDL cholesterol (>0.9 mmol/l). Glucose self-monitoring (either urine or blood) was only practiced by 50% of patients. Glycaemic control (HbA1c) was unsatisfactory as majority of patients had HbA1c>7.4% (73%) and 50% had fasting blood glucose (FBG)>7.8 mmol/l. Cataract (26%), neuropathy (42%) and cerebral stroke (6%) were the most frequently reported complications. Clearly, the level of glycaemic control in majority of patients is below satisfaction. Effective education must be emphasised in the management of diabetes.

摘要

“亚洲糖尿病关爱”项目的目的是收集12个亚洲国家患者的糖尿病控制、管理及并发症状况的数据。信息从医疗记录、访谈及实验室评估中提取。大部分(96%)患者被诊断为2型糖尿病,平均年龄(±标准差)为59.3±12.5岁,平均糖尿病病程为9.4±7.0年。平均体重指数(BMI)为24.7±4.9kg/m²,大部分(60%)患者的BMI≤25kg/m²。大部分(70%)患者接受口服降糖药(OADs)治疗,15%使用胰岛素,10%采用胰岛素与OAD联合治疗,5%采用饮食控制。在接受OADs治疗的患者中,大多数(44%)使用两种或更多药物。大部分患者(≥79%)的甘油三酯(<2.2mmol/l)、总胆固醇(<6.5mmol/l)和高密度脂蛋白胆固醇(>0.9mmol/l)代谢控制良好。仅50%的患者进行血糖自我监测(尿液或血液)。血糖控制(糖化血红蛋白)不理想,因为大部分患者的糖化血红蛋白>7.4%(73%),50%的患者空腹血糖(FBG)>7.8mmol/l。白内障(26%)、神经病变(42%)和脑卒中(6%)是最常报告的并发症。显然,大多数患者的血糖控制水平未达满意标准。在糖尿病管理中必须强调有效的教育。

相似文献

1
Epidemiology of diabetes mellitus in Western pacific region: focus on Philippines.西太平洋地区糖尿病流行病学:聚焦菲律宾。
Diabetes Res Clin Pract. 2000 Oct;50 Suppl 2:S29-34. doi: 10.1016/s0168-8227(00)00176-5.
2
The Diabcare-Asia 1998 study--outcomes on control and complications in type 1 and type 2 diabetic patients.1998年亚洲糖尿病护理研究——1型和2型糖尿病患者的控制情况及并发症结果
Curr Med Res Opin. 2002;18(5):317-27. doi: 10.1185/030079902125000822.
3
[Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].[全科医生报告的糖尿病患病率、抗糖尿病治疗及慢性糖尿病并发症情况]
Przegl Lek. 2005;62(4):201-5.
4
The current state of diabetes management in Taiwan.
Diabetes Res Clin Pract. 2001 Nov;54 Suppl 1:S55-65. doi: 10.1016/s0168-8227(01)00310-2.
5
A window on the current status of diabetes mellitus in Singapore--the Diabcare-Singapore 1998 study.新加坡糖尿病现状之窗——1998年新加坡糖尿病护理研究
Singapore Med J. 2001 Nov;42(11):501-7.
6
Epidemiological analysis of patients with Type 2 diabetes in France.
J Diabetes Complications. 2000 Sep-Oct;14(5):242-9. doi: 10.1016/s1056-8727(00)00120-3.
7
An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studies.一项针对亚洲患者糖尿病管理情况的专科医生审计:1998年和2003年亚洲糖尿病管理研究(Diabcare-Asia)
Curr Med Res Opin. 2008 Feb;24(2):507-14. doi: 10.1185/030079908x261131.
8
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.瑞格列奈:对其在2型糖尿病治疗中应用的药物经济学综述
Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005.
9
[Prevalence of type II diabetes mellitus in population of Krakow].[克拉科夫人群中2型糖尿病的患病率]
Pol Arch Med Wewn. 2001 Sep;106(3):771-9.
10
Clinical profile of lean NIDDM in South India.印度南部瘦型非胰岛素依赖型糖尿病的临床特征
Diabetes Res Clin Pract. 1997 Nov;38(2):101-8. doi: 10.1016/s0168-8227(97)00088-0.

引用本文的文献

1
Diagnosing peripheral neuropathy in South-East Asia: A focus on diabetic neuropathy.诊断东南亚的周围神经病变:关注糖尿病性周围神经病变。
J Diabetes Investig. 2020 Sep;11(5):1097-1103. doi: 10.1111/jdi.13269. Epub 2020 May 21.
2
Risk factors for amputation in patients with diabetic foot ulcer in southwest Iran: a matched case-control study.伊朗西南部糖尿病足溃疡患者截肢的危险因素:一项配对病例对照研究。
Epidemiol Health. 2015 Oct 5;37:e2015044. doi: 10.4178/epih/e2015044. eCollection 2015.
3
Use of natural compounds in the management of diabetic peripheral neuropathy.
天然化合物在糖尿病周围神经病变管理中的应用。
Molecules. 2014 Mar 5;19(3):2877-95. doi: 10.3390/molecules19032877.
4
Hyperglycemia and type 2 diabetes among Filipino women in the Philippines, Hawaii, and San Diego.菲律宾、夏威夷和圣地亚哥的菲律宾女性中的高血糖和2型糖尿病。
Diabetes Res Clin Pract. 2006 Mar;71(3):306-12. doi: 10.1016/j.diabres.2005.07.012. Epub 2005 Oct 19.